A Passion for Biotech Innovation

Focusing on re-emerging diseases, pandemic diseases and specifically on respiratory diseases like
Flu, Pertussis and COVID-19.
Discover More!
  1. Home
  2. /
  3. Company

BioNet is a biotech company focusing on bio-innovation and access to genetically-designed vaccines.

BioNet is the world’s only manufacturer of licensed recombinant pertussis vaccines containing a genetically-inactivated pertussis toxin (PTgen).

BioNet’s vision to forge global product partnerships has led to the rapid development of genetic vaccines using DNA and mRNA technology platforms. Clinical development of BioNet COVID-19 DNA candidate vaccines are conducted in Australia by Technovalia and partners. BioNet has been manufacturing a mRNA COVID-19 vaccine developed by Chulalongkorn University and the University of Pennsylvania.

BioNet is now developing a pancoronavirus mRNA vaccine with the support from CEPI. BioNet is leading a global consortium composed of US and Thai universities and the International Vaccine Institute.

BioNet’s main locations are Bangkok, Thailand and Lyon, France with a vaccine manufacturing plant in Ayutthaya, Thailand. Our team of more than 200 people across the globe are fully dedicated to the development, manufacturing and supply of vaccines against re-emerging and pandemic diseases.

Our Vision

Our vision is to become a leading vaccine company sharing biotech innovation and partnering networks to enable access to life-saving vaccines anywhere in the world.

Our Mission

“A world free of any preventable disease is our dream. To make this dream come true is our mission.” We are all passionate about our mission at BioNet.

Quality Policy

BioNet commits to develop and manufacture innovative high-quality vaccines that comply with applicable regulatory requirements.
BioNet is led by international senior executives
who bring their broad experience from the vaccine industry.